ABSTRACT
Microalbuminuria strongly predicts cardiovascular morbidity and mortality, clinical nephropathy, and progression of renal disease in high-risk populations. We recommend screening patients with type 2 diabetes, older patients with type 1 diabetes, and older patients with stage 2 hypertension or higher (ie, ≥ 160/100 mm Hg).
- Copyright © 2003 The Cleveland Clinic Foundation. All Rights Reserved.